1,121 results on '"Borer, Jeffrey S"'
Search Results
102. Editorʼs Note
103. Comparison of tomographic and planar radionuclide ventriculography in the assessment of regional left ventricular function in patients with left ventricular aneurysm before and after surgery
104. Risk stratification in the elderly patient after coronary artery bypass grafting: The prognostic value of radionuclide cineangiography
105. Development of cardiovascular drugs: The U.S. regulatory milieu from the perspective of a participating nonregulator
106. The clinical development of percutaneous heart valve technology: A position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society of Cardiovascular Angiography and Intervention (SCAI)
107. The clinical development of percutaneous heart valve technology: A position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI)
108. Editorʼs Note: Receiving the Torch
109. Combined rest and exercise electrocardiographic repolarization findings in relation to structural and functional abnormalities in asymptomatic aortic regurgitation
110. Drug Insight: If inhibitors as specific heart-rate-reducing agents
111. Heart failure due to chronic experimental aortic regurgitation
112. Preoperative Predictors of Late Postoperative Outcome among Patients with NonischemicMitral Regurgitation with ‘High Risk’ Descripto rs and Comparison with Unoperated Patients
113. Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis
114. Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen
115. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
116. Application of Transcatheter Repair to Tricuspid Regurgitation
117. Medical Misinformation
118. Medical misinformation: vet the message!
119. Fibrosis, Myocyte Degeneration and Heart Failure in Chronic Experimental Aortic Regurgitation
120. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial
121. Reduced left ventricular contractility, increased diastolic operant stiffness and high energetic expenditure in patients with severe aortic regurgitation without indication for surgery.
122. Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation
123. Right and left ventricular performance 10 years after Mustard repair of transposition of the great arteries
124. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance
125. Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events
126. Identification of 'surgical' coronary anatomy by exercise radionuclide cineangiography
127. Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery
128. Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension
129. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial
130. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
131. Raymond John Lipicky, MD
132. Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Preoperative Contractility Measurement
133. Role of Payers in the Development of Cardiovascular Therapeutics
134. Myocardial Connexin43 Expression in Left Ventricular Hypertrophy Resulting from Aortic Regurgitation
135. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial
136. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval
137. Prevention of Sudden Death: Selection of Patients at Risk
138. Echocardiographic assessment of cardiomyopathies
139. ASNC Announcement
140. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement
141. Effect of gender on outcomes after cardiac resynchronization therapy in patients with a narrow QRS complex
142. Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT
143. Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT
144. Impact of Beta-Blockade on Cardiac Events in Patients with Chronic Severe Nonischemic Mitral Regurgitation
145. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial
146. Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al.
147. Streamlining cardiovascular clinical trials to improve efficiency and generalisability
148. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis
149. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
150. Use and Disuse of Observational Research: The Case of Remote Monitoring in Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.